SCHEMBL6538742

SCHEMBL6538742

CCOC(=O)/C=C/c1nc(-c2ccccc2)c(-c2ccc(=O)n(C(C)C)n2)cc1C(=O)OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
MAPT P10636 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTGS2 P35354 1/20 0.36
HTT P42858 1/20 0.36
PTGS1 P23219 1/20 0.36
POLB P06746 2/20 0.36
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
PDE4B Q07343 1/20 0.34
ADORA3 P0DMS8 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HPGDS O60760 1/20 0.34
CCNC P24863 1/20 0.34
CDK8 P49336 1/20 0.34
MDM2 Q00987 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538316 0.85 TP53 (0.39) ALDH1A1KDM4EHPGDMAPTPTGS1
SCHEMBL6538457 0.82 MAPT (0.41) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL6538296 0.81 ADORA3 (0.44) ALDH1A1KDM4EHPGDMAPTL3MBTL1
SCHEMBL6538824 0.81 MEN1 (0.39) ALDH1A1KDM4EHPGDMAPTPTGS1
SCHEMBL5149084 0.80 ALDH1A1 (0.40) ALDH1A1KDM4EGLAHPGDMAPT
SCHEMBL5149088 0.80 ALDH1A1 (0.40) ALDH1A1KDM4EGLAHPGDMAPT
SCHEMBL6538389 0.80 ALDH1A1 (0.38) ALDH1A1KDM4EGLAHPGDMAPT
SCHEMBL6538391 0.80 ALDH1A1 (0.38) ALDH1A1KDM4EGLAHPGDMAPT
SCHEMBL6538930 0.80 POLB (0.42) ALDH1A1KDM4EMAPTPOLBPDCD1
SCHEMBL6538650 0.78 MAPT (0.39) ALDH1A1KDM4EHPGDMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040067955-A1 Pyridazinone compound and pharmaceutical use thereof FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067955-A1 Pyridazinone compound and pharmaceutical use thereof ADORA1, ADORA2A, P2RX5 ALDH1A1 1399/4885KDM4E 3052/4885GLA 733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.